VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | The impact of mutational & copy number signatures on the outcomes of patients with multiple myeloma

Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone, New York, NY. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA, discusses mutational and copy number signatures in multiple myeloma, discussing the impact of these signatures on prognosis and response to therapy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter